BOK Financial’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

BOK Financial’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,366	Closed	-$618K	–	961
2018 Q2	$618K	Buy	7,366 +2,836	+63%	+$208K	0.02%	614
2018 Q1	$278K	Buy	+4,530	New	+$273K	0.01%	795
2017 Q1	–	Sell	-9,222	Closed	-$1M	–	924
2016 Q4	$1M	Sell	9,222 -1,838	-17%	-$219K	0.03%	466
2016 Q3	$1.82M	Buy	+11,060	New	+$1.74M	0.06%	342
2016 Q1	–	Sell	-1,372	Closed	-$205K	–	885
2015 Q4	$205K	Buy	1,372 +66	+5%	+$11.2K	0.01%	791
2015 Q3	$217K	Sell	1,306 -131	-9%	-$28.8K	0.01%	760
2015 Q2	$347K	Sell	1,437 -123	-8%	-$32.8K	0.01%	657
2015 Q1	$440K	Buy	+1,560	New	+$338K	0.01%	577

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BOK Financial's ICPT Position: Q3 2018 in Review

BOK Financial sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2018, closing a stake of 7,366 shares — an estimated $618K sold.

BOK Financial first reported a position in ICPT in Q1 2015 and held it in 8 quarters. The position peaked at $1.82M in Q3 2016. 175 funds tracked by Wall St. Rank hold ICPT as of Q3 2018.

BOK Financial reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
BOK Financial sold 7,366 Intercept Pharmaceuticals, Inc. shares in Q3 2018, an estimated $618K.
BOK Financial first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 8 quarters.
BOK Financial's Intercept Pharmaceuticals, Inc. position peaked at $1.82M in Q3 2016.
175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2018.

Based on BOK Financial's 13F filing for Q3 2018, filed 13 Nov 2018.